{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:56:55Z","timestamp":1790193415236,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","doi-asserted-by":"publisher","award":["24K11502"],"award-info":[{"award-number":["24K11502"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Scientific Research","award":["25K02673"],"award-info":[{"award-number":["25K02673"]}]},{"name":"Grant-in-Aid for Early-Career Scientists","award":["25K19539"],"award-info":[{"award-number":["25K19539"]}]},{"DOI":"10.13039\/501100008883","name":"Nagoya City University","doi-asserted-by":"publisher","award":["202401102"],"award-info":[{"award-number":["202401102"]}],"id":[{"id":"10.13039\/501100008883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tertiary lymphoid structures (TLS) are ectopic lymphoid formations within or around tumours. They are emerging as important predictors of prognosis and response to immune checkpoint inhibitors (ICIs) in various cancers. However, in Merkel cell carcinoma (MCC), the correlation between TLS and ICI response has not yet been evaluated. Furthermore, the criteria for assessing TLS maturity vary by report, and there is no unified consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the relationship between TLS and ICI responsiveness in MCC using spatial proteomics at the single-cell level. By comparing the spatial characteristics of TLS in people whose disease responds to ICI and those whose disease does not, we also aimed to identify features related to functionality of TLS, distinct from the previously reported maturity of TLS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed 24 TLS from 13 patients with MCC treated with the anti-programmed cell death ligand 1 antibody avelumab, using the PhenoCyclerTM platform with 16 oligonucleotide-labelled antibodies. Infiltrating immune cells and tumour cells were phenotyped based on machine learning, and spatial single-cell analysis was performed, including cellular neighbourhood analysis and cell\u2013cell correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings revealed that the number of TLS positively correlated with survival and ICI response (P = 0.03). The number of TLS observed in tumours was significantly higher in those whose disease responded to the ICI compared with those whose disease did not (P = 0.004). Cellular neighbourhood analysis and cell\u2013cell correlation analysis demonstrated that in functional TLS in those whose disease responded to treatment, T cells infiltrated densely within B-cell clusters, extending close to follicular dendritic cells, and that CD4+ T cells adjacent to CD8+ T cells express programmed cell death protein 1 (PD-1). In contrast, in TLS in those whose disease did not respond to treatment, although the B-cell density was high, T cells did not infiltrate B-cell cluster areas but instead resided in the peripheral areas. Furthermore, it was found that CD8+ T cells and CD4+ T cells approaching B cells expressed PD-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found a significant positive correlation between the number of TLS and ICI response in MCC. Additionally, our results suggest that the immune composition and spatial configuration within TLS may be important determinants of ICI efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf525","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T12:45:32Z","timestamp":1766666732000},"page":"888-898","source":"Crossref","is-referenced-by-count":3,"title":["Spatial proteomics of tertiary lymphoid structures reveals correlation with immunotherapy response in Merkel cell carcinoma"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-7782","authenticated-orcid":false,"given":"Motoki","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1335-7100","authenticated-orcid":false,"given":"Dai","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Dermatologic Oncology, National Cancer Center Hospital , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University School of Medicine , Sapporo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Yoshimitsu","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Magara","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kano","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jichi Medical University Saitama Medical Center , Shimotsuke ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Gunma University Graduate School of Medicine , Maebashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kiniwa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shinshu University , Matsumoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Environment Immuno-Dermatology, Yokohama City University , Yokohama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Skin Oncology\/Dermatology, Saitama Medical University International Medical Center , Hidaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Nagase","sequence":"additional","affiliation":[{"name":"Nagase Dermatology Clinic , Saga ,","place":["Japan"]},{"name":"Department of Dermatology, Fukuoka University Faculty of Medicine , Fukuoka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimichi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences , Nagoya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"2026041711423069000_ljaf525-B1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11154-017-9433-0","article-title":"Merkel cell carcinoma: epidemiology, pathogenesis, diagnosis and therapy","volume":"18","author":"Amaral","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"2026041711423069000_ljaf525-B2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"2026041711423069000_ljaf525-B3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s41388-017-0073-3","article-title":"Are there multiple cells of origin of Merkel cell carcinoma?","volume":"37","author":"Sunshine","year":"2018","journal-title":"Oncogene"},{"key":"2026041711423069000_ljaf525-B4","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1158\/1078-0432.CCR-18-4159","article-title":"The genomic landscape of Merkel Cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy","volume":"25","author":"Knepper","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026041711423069000_ljaf525-B5","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1200\/JCO.20.00201","article-title":"Neoadjuvant nivolumab for patients with resectable Merkel cell carcinoma in the CheckMate 358 trial","volume":"38","author":"Topalian","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026041711423069000_ljaf525-B6","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jid.2020.12.037","article-title":"Quality is king: fundamental insights into tumor antigenicity from virus-associated Merkel cell carcinoma","volume":"141","author":"Lahman","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026041711423069000_ljaf525-B7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1468-3083.2002.374_2.x","article-title":"Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon?","volume":"16","author":"Sais","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026041711423069000_ljaf525-B8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1346-8138.16232","article-title":"Immune activity in Merkel cell carcinoma","volume":"49","author":"Nakamura","year":"2022","journal-title":"J Dermatol"},{"key":"2026041711423069000_ljaf525-B9","doi-asserted-by":"crossref","first-page":"115121","DOI":"10.1016\/j.ejca.2024.115121","article-title":"An updated review of immune checkpoint inhibitors in cutaneous oncology: beyond melanoma","volume":"214","author":"Pham","year":"2025","journal-title":"Eur J Cancer"},{"key":"2026041711423069000_ljaf525-B10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11912-025-01693-z","article-title":"Merkel cell carcinoma: current treatment landscape and emerging therapeutic targets","volume":"27","author":"Pan","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"2026041711423069000_ljaf525-B11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/cancers17071212","article-title":"Understanding Merkel cell carcinoma: pathogenic signaling, extracellular matrix dynamics, and novel treatment approaches","volume":"17","author":"Konstantaraki","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026041711423069000_ljaf525-B12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"2026041711423069000_ljaf525-B13","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"2026041711423069000_ljaf525-B14","doi-asserted-by":"crossref","first-page":"811586","DOI":"10.3389\/fonc.2022.811586","article-title":"Tertiary lymphoid \u00adstructures and chemokine landscape in virus-positive and \u00advirus-\u00adnegative Merkel cell carcinoma","volume":"12","author":"Nakamura","year":"2022","journal-title":"Front Oncol"},{"key":"2026041711423069000_ljaf525-B15","doi-asserted-by":"crossref","first-page":"e15062","DOI":"10.1111\/exd.15062","article-title":"Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression","volume":"33","author":"Nakamura","year":"2024","journal-title":"Exp Dermatol"},{"key":"2026041711423069000_ljaf525-B16","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2026041711423069000_ljaf525-B17","doi-asserted-by":"crossref","first-page":"107523","DOI":"10.1016\/j.celrep.2020.107523","article-title":"CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues","volume":"31","author":"Stoltzfus","year":"2020","journal-title":"Cell Rep"},{"key":"2026041711423069000_ljaf525-B18","doi-asserted-by":"crossref","first-page":"1106434","DOI":"10.3389\/fonc.2023.1106434","article-title":"Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures","volume":"13","author":"Magara","year":"2023","journal-title":"Front Oncol"},{"key":"2026041711423069000_ljaf525-B19","doi-asserted-by":"crossref","first-page":"217491","DOI":"10.1016\/j.canlet.2025.217491","article-title":"Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: advancing towards clinical application","volume":"613","author":"Cui","year":"2025","journal-title":"Cancer Lett"},{"key":"2026041711423069000_ljaf525-B20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"2026041711423069000_ljaf525-B21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"2026041711423069000_ljaf525-B22","doi-asserted-by":"crossref","first-page":"1369626","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"2026041711423069000_ljaf525-B23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2026041711423069000_ljaf525-B24","doi-asserted-by":"crossref","first-page":"1413067","DOI":"10.3389\/fimmu.2024.1413067","article-title":"Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy","volume":"15","author":"Bao","year":"2024","journal-title":"Front Immunol"},{"key":"2026041711423069000_ljaf525-B25","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"2026041711423069000_ljaf525-B26","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.labinv.2023.100063","article-title":"Standardized pathology screening of mature tertiary lymphoid structures in cancers","volume":"103","author":"Vanhersecke","year":"2023","journal-title":"Lab Invest"},{"key":"2026041711423069000_ljaf525-B27","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00262-022-03353-8","article-title":"Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma","volume":"72","author":"Wakasu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"2026041711423069000_ljaf525-B28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"2026041711423069000_ljaf525-B29","doi-asserted-by":"crossref","first-page":"e1378844","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer","volume":"7","author":"Posch","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026041711423069000_ljaf525-B30","doi-asserted-by":"crossref","first-page":"1096220","DOI":"10.3389\/fimmu.2023.1096220","article-title":"Follicle-like tertiary lymphoid structures: a potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma","volume":"14","author":"Liang","year":"2023","journal-title":"Front Immunol"},{"key":"2026041711423069000_ljaf525-B31","doi-asserted-by":"crossref","first-page":"2528109","DOI":"10.1080\/2162402X.2025.2528109","article-title":"Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma","volume":"14","author":"Zhang","year":"2025","journal-title":"Oncoimmunology"},{"key":"2026041711423069000_ljaf525-B32","doi-asserted-by":"crossref","first-page":"e012224","DOI":"10.1136\/jitc-2025-012224","article-title":"Tertiary lymphoid structures in Merkel cell carcinoma facilitate na\u00efve and central memory T-cell infiltration linked to immunotherapy response","volume":"13","author":"Srinivas","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026041711423069000_ljaf525-B33","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/cas.70105","article-title":"CXCL13 and CCL21 induce tertiary lymphoid structures and enhance the efficacy of immunotherapy for melanoma","volume":"116","author":"Yoshimitsu","year":"2025","journal-title":"Cancer Sci"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf525\/66149984\/ljaf525.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/5\/888\/66149984\/ljaf525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/5\/888\/66149984\/ljaf525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:42:44Z","timestamp":1776440564000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/5\/888\/8407105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,12,29]]},"published-print":{"date-parts":[[2026,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf525","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,12,29]]}}}